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IN an earlier publication (Robinson, 1948) the results obtained in a study of
17-ketosteroid excretion in men of different age-groups were reported. Special
attention was paid to quantitative dlifferences in total ketosteroid excretion
during the later decades of life. The primary object of the work was to form a
basis for comparison with similar quantitative data from cases ofprostatic cancer.
In parallel with this quantitative study a qualitative examination of these
urines was also undertaken. This involved separation and estimation of the
individual components of the total ketosteroid complex present in urinary
extracts. Such a separation can be achieved by chromatographic methods, and
many investigators have described procedures (e.g. Callow, 1939; Wolfe, Fieser
and Friedgood, 1941; Dobriner, Rhoads, Lieberman, Hill and Fieser, 1944;
Dobriner, Lieberman and Rhoads, 1948). In most ofthe work described by these
authors the components were recognized by isolation and identification by the
usual chemical criteria such asmelting-point andopticalrotation. Comparatively
large quantities of material are required for identification by isolation, and the
method is unsuitable for the amounts obtained from small specimens of urine.
Dingemanse, Huis in't Veld and de Laat (1946) described a method for
chromatographic-colorimetric determination of urinary 17-ketosteroids which is
applicable to the amounts encountered in one day's output ofurine. The method
involves adsorption of the 17-ketosteroids on a column of alumina from benzene
solution followed byfractional elution with benzene ofincreasing ethanol content.
The amount of 17-ketosteroid present ineach eluate is determined bythe Zimmer-
mann reaction. Preliminary experiments with the method described by these
authors showed that separation and estimation of the steroid components could
be achieved, but that reproducible results depended on careful standardization
of the alumina and of the conditions of elution. With these precautions this
method was adopted in the present work.
~~- 1~~METHODS AND MATRIALS.
(1) Preparation of urine extract8.
Hydrolysis and extraction of the urines were carried out by the same method
as that given in the earlier paper (Robinson, 1948). For the chromatograms
5 mg. of total 17-ketosteroid was found to be the most suitable amount, and
sufficient urine from a 24 or 48-hour collection was hydrolysed and extracted to
furnish a quantityin excess of5 mg. Therequiredvolume ofurine was estimated
approximately by a preliminary assay of total 17-ketosteroid on a small aliquotURINARY 17-KETosTERomIDs
of the urine. The bulk extract was also dissolved in alcohol and assayed for
total ketosteroid. An amount of alcoholic solution containing about 5 mg. was
evaporated to dryness, and two successive portions of pure benzene (5 ml.) added
and distilled off to remove the last traces of alcohol prior to solution in benzene
for adsorption on alumina.
(2) Stamndardization of alumina and adsorption columns.
Since Merck's alumina was not available, many samples of alumina were
examined in order to obtain a product with the desired activity. Spence "Type
H "alumina was finally selected for this purpose. When samples ofthis alumina
are exposed to air (by spreading the material in thin layers and exposing it to
the moist air of the laboratory) they gradually lose their adsorptive activity.
This loss of activity is accompanied by a decrease in pH of aqueous suspensions
of the alumina. Suspensions prepared by mixing alumina with distilled water
(1 part A1203 with 2 parts distilled water, by weight) show an initial pH of 105
beforedeactivation and agradual decrease topH 9-3after 2 to 3 days' deactivation.
The adsorptive power of the alumina was checked at intervals during the deacti-
vating process by employing Brockman's method of standardization, using
mixtures of dyes (Brockmann and Schodder, 1941). A suitable dye mixture
consists of 20 mg. ofSudan red together with 20 mg. ofSudan yellow dissolved in
10 ml. of benzene and diluted to a total volume of 50 ml. with petroleum ether
(b.p. 40-60°). The dyes were obtained from Messrs. Gurr, and further purified
by solution in benzene and filtration through alumina followed by crystallization
from benzene (Sudan red) or alcohol (Sudan yellow). For standardization, 1 ml.
of this dye solution is adsorbed on a column (50 x 14 mm.) prepared from a
suspension of alumina (7 g.) in benzene-petroleum ether (1:4) and eluted with
30 ml. of the same solvent mixture. The alumina is considered to have suitable
adsorptive power when the yellow band reaches the bottom of the column, while
the red band moves down about 10 mm.
The alumina columns for adsorption of the urine extracts are contained in
glass tubes of 14 mm. internal diameter fitted with glass taps at the lower end.
Above the tap a plug of cotton-wool is inserted and the alnmina filling is added
above the plug. Each adsorption column contains exactly 13 g. of alumina,
which forms a column approximately 10 cm. high. The dead space above the
alumina is sufficient to hold 60-70 ml. of solvent. The column of alumina is
formed by pouring a mixture of alumina and benzene into the tube and allowing
packing ofthe alumina to take place by gravity alone. Excess benzene is drawn
off through the tap until the benzene level reaches the top of the alumina; the
tap is then closed and the column stoppered until required.
(3) Adsorption and elution ofurine extracts.
The urine extract (containing approximately 5 mg. of total 17-ketosteroids) is
dissolved in 50 ml. of dry thiophene-free benzene and the solution poured on to
the prepared alumiina column. The benzene eluate comprises Fraction 0.
Elution is then continued with (a) 350 ml. of benzene, (b) 1200 ml. of benzene
containing 0-1 per cent. (v/v) ethanol, (c) 500 ml. of benzene containing 0-5 per
cent (v/v) ethanol, (d) 100 ml. of ethanol. These solvents are passed through
the column successively, the tube above the alumina being kept full (except
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when the composition ofthe eluting fluid is changed),.and theeluates are collected
in 50 ml. fractions. These fractions are numbered successively 1-43.
(4) Assay ofelutedfractions.
The solvent isremovedfrom each fractional eluate and theresidue dissolved in
2 ml. ofabsolute ethanol. Analiquot (0-2 ml.) ofthis solution is then assayed by
the Callow-Zimmermann method for 17-ketosteroids. The observed colorimetric
values are corrected when necessary for interfering chromogens (Robinson, 1948).
(5) Recording ofchronatograms and identification ofcon8tituents.
The amount of 17-ketosteroid in each eluate is plotted as the ordinate against
an abscissa corresponding to the serial number of the eluate. The curve con-
structed from these points consists of a series of peaks. With normal urine
as many as nine peaks may occur, but in no case was the number less than seven.
Dingemanse, Huis in'tVeldandde Laat (1946) adopted a systemofnumbering
in which successive peaks on the curve were indicated by Roman numerals i-vi,
the lowest numeral corresponding to the peak with the lowest eluate serial
numbers. This system was used in the present work to facilitate comparison
with the results of these authors. In some urines, however, small quantities
of a component occurred which appeared to be different from any of the 8 main
fractions, and this component was allocated to a sub-group Hia. The Dutch
workers considered the chief 17-ketosteroid components of their 8 fractions to
be (Huis in't Veld, 1948):
Fraction I A3:5-androstadien-17-one.
3-chloro-A5-androsten-17-one.
A2-androsten-17-one.
,, IH "17-ketosteroid II"
,, m dehydrosndterone and isoandrosterone (i.e.
3-(f)-hydroxyketosteroids)
IV,, V androsterone.
,, v aetiocholan-3-(a)-ol-17-one.
,, vI unidentified.
,, VII ,
,, vi ,, artefacts.
The substances in Fraction i are considered to be artefacts arising from the
action of boiling hydrochloric acid during the hydrolysis. The substance
originarlly referred to as "17-ketosteroid HI" (Dingemanse, Huis in't Veld and
de Laat, 1946; Dingemanse, Huis in't Veld and Hartogh-Katz, 1948a) was later
shown to be i-androsten-6-ol-17-one (Dingemanse, Huis in't Veld and Hartogh-
Katz, 1948b; Barton and Klyne, 1948). The Dutch workers isolated this
substance from the urine of a two-year-old girl with an adrenal tumour, but
found only small quantities in the urine of normal persons. In the presence of
hydrochloric acid this substance gives rise to chlorodehydroisoandrrone and
dehydroisoandrosterone, andsuch a conversion may occurdurijg the preliminary
hydrolysis of the urine.
In the present investigation confirmation of these identities for peaks mn,
rv and v was obtained (a) by the isolation of the constituents ofpeaks rv and v
and the preparation of crystalline acetates and benzoates therefrom, (b) by the
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application of a colour reaction (Patterson, 1947) to the constituents of peak ni,
(c) by identification of the peaks formed by authentic specimens of dehydro-
i&oandrosterone, androsterone and aetiocholan-3-(x)-ol-17-one.
In order to study the reproducibility of the method and the type of curves
to be expected, known amounts of dehydroisoandrosterone, androsterone and
aetiocholan-3-(x)-ol-17-one were chromstographed alone and in mixtures con-
taining varying proportions of these three steroids. The curves obtained in
these experiments revealed immediately a problem that has to be faced in deter-
mining the amount of ketosteroid represented by any one peak. This is the
complication introduced by the fact that the minimum values in the depressions
between peaks are not always zero. The question therefore arises as to how the
amount of ketosteroid corresponding to such minimum values should be par-
titioned between two peaks on either side of the minimum. Three treatments
were considered: (i) half of the minimum value might be allotted to each of the
adjacent peaks; (ii) the whole of the mimmum value might be added to the
preceding peak; (iii) the descending curve of the preceding peak might be pro-
jected down to the abscissa axis, and the additional values thus formedadded to
the preceding peak while corresponding deductions are made from the succeeding
peak. These three methods were tested by their application to the model
chromatograms obtained with the known mixtures of the three steroids men-
tioned above. In general it was found that the projection method (iii) gave a
closer approximation to the actual amounts of the individual steroids than did
either method (i) or method (ii). This method was therefore adopted as standard
for computing the amounts of 17-ketosteroids represented by different peaks.
A striking example of the reproducibility of the method has recently been
encountered. Two specimens of urine from the same subject were examnined
at an interval of one year. The two curves were almost identical.
RESULTS.
Urines of 19 normal males varying in age from 3 to 73 years were examined.
Representative curves obtained from some of these urmes are shown in Fig. 1.
The curve ofCase 0 was obtained on an extract from a 10-day collection of urine
from a boy aged three. In Cases 1 and 2 it was necessary to collect urine for 2 to
3 days in order to obtain sufficient ketosteroid for analysis. The remaining
curves were obtained on aliquots of single 24-hour specimens. The percentage
distribution ofthe total ketosteroids among the different peaks is given in Table I
for all the normal males investigated with the exception of Case 0, in which the
peaks normally present in adult curves could not be differentiated.
Urines from 2 cases of benign hyperplasia of the prostate and from 6 cases of
carcinoma of this gland were also examined, and the corresponding curves and
percentage compositions ofthese extracts are shown in Fig. 2 and Table II.
DISCUSSION.
Chromatographic analysis of the 17-ketosteroids present in normal or patho-
logical urines usually reveals a complicated pattern. Part of the complication
undoubtedly arises owing to the formation of artefacts during hydrolysis. In
some cases investigated as many as 9 peaks appeared on the curves, indicating
at least this number of different constituents. Even more components may,
5
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Eluate number
Eo. 1.-17-Ketosteroid content of eluates from chromatograms ofurines from normal males
Case 0 (not included in Table I). Three-year-old boy. Incomplete differentiation into individual peaks.
Cases 1, 8, 17 represent the predominant type in which androsterone exceeds aetio-
cholanolone.
Cases 2 and 5 are unusual types in which aetiocholanolone exceeds androsterone.
Case 13 is a man, aged 50; 17-ketosteroid output 20 mg. per day; dehydroi/andro-
sterone 34 per cent oftotal ketosteroid.
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Fio. 2.-17-Ketosteroid content of eluates from chromatograms of urines from patients with
prostatic disease.
Cases 19 and 20, prostatic hyperplasia.
Cases 21-26, carcinoma of the prostate.
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TABLE I.-Percentage Composition of 17-Ketosteriod Complex from Urines
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Age
(years).
11
12
17
25
28
28
28
36
37
40
46
48
50
53
54
59
65
73
L
14-0
15-0
14-0
19-1
10-5
18-2
10-0
15-5
8-1
8-7
7-1
10-5
18-4
14-4
14-1
12-9
8-0
9-9
II.
3.
.
3-0
3-0
0-6
5. 6
0-8
0-9
1-0
6-9
4. 6 4-6
3-5
2-6
4-1
4-4
2-7
of
IIa.
I. .
3 2
I .I 1 1
2 4
1-7
0-4
1-3
2-4
*o-
*o-
Normal
IIL
2-0
12-1
5 -3
19-4
4-1
17-2
8-9
11-3
12-6
3-3
5 -4
11-0
34-0
13-0
4-8
18-0
9-5
18-0
Males.
Iv.
22-0
8 -4
25-3
30-4
26-2
23-0
33 -0
37-0
46-0
49-0
36-8
27-0
19-4
23-8
32-6
28-8
37-0
35-6
V.
15-8
20-8
30-0
15-5
38-0
24-0
32-0
18-0
21 -3
11 -0
32-2
31 -0
20-3
23-8
23-7
24-6
31-8
20-8
VI.
5-1
19-1
8-9
4-5
9-7
1-7
5-5
2-4
2-9
5.
.
5-0
5-3
1 -6
3-3
5-3
3 -3
2-1
*o.
IL
35-7
18-7
8-2
5-9
6-2
6-4
5-7
11-5
7-1
15-5
7-9
7-8
3-7
14-1
12-1
5-3
5-2
8-8
VIII.
5-7
2-9
1-9
4-7
4-3
3-8
1-9
3-0
1-1
6-0
3-7
2-6
2-3
3-0
4-7
0-8
2-1
4-4
TABLE II.-Percentage Compositon of 17-Ketosteroid
with Prostatic Disease.
Cas. No.
19 (B)
20 (B)
21 (C)
22 (C)
23 (C)
24 (C)
25 (C)
26 (C)
L
8 -6
9-4
15-2
11-3
2-1
13-1
8-0
9-0
II.
4-6
5-8
4-6
4-1
15-9
3-7
9-9
1-8
IIa.
8
.
8 -1
. .
IIL
5-9
12-0
10-0
16-3
5-1
5-1
5-5
4-0
IV.
28-9
12-7
21-5
22-8
19-0
23-4
21-3
26-4
V.
36-9
28-3
29-6
33-1
33-6
37-0
34-1
35-9
Vil.
1-7
10-2
8-1
2-5
4-4
3-2
3-8
3-6
vII.
9-2
10-6
8-4
7-8
15-1
9-9
15-4
13-4
(B) indicates benign enlargement of the prostate, (C) carcinoma of prostate.
of course, actually be present, since two or more 17-ketosteroids may be eluted
together (this is known to occur in peak m, which may contain both dehydro-
isoandrosterone and isoandrosterone). An examination of Tables I and II
shows, however, that the major portion of the ketosteroids is accounted for in
peaks mI, IV and v, that is, those corresponding to 3-(P)-hydroxyketosteroids,
androsterone, and aetiocholan-3-(x)-ol-17-one respectively. Further work may
show that certain minor peaks, including those shown only by some urine extracts
(e.g. Hiia), may have even greater biological significance than the major ones,
but the amounts isolated from these eluates have so far been too small for
identification.
Ifattention is confined to the three major peaks m, iv and v, an examination
of Table I shows no obvious trend in their relative amounts with age. Peak II,
average value 11-7 per cent, ranges from 2 to 34 per cent of the total, peak iv
averages 30 per cent, with a range from 8-4 to 49 per cent, and peak v has a mean
of 24-2 per cent, with a range from 11 to 38 per cent. It will be seen that the
average output of androsterone exceeds that of actiocholanolone in the ratio
1-25:1-0. Only in three of the 18 cases shown in Table I does the output of
aetiocholanolone notably exceed that of androsterone (Cases 2, 3 and 5); in the
other 15 cases the amount of the former ketosteroid is either approximately
equal to or less than the amount of androsterone.
Complex in Males
VIII.
4-0
3-0
2-9
2-1
4-6
4-6
1-7
5-9
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A comparison of the data shown in Table II with those of Table I shows,
however, what appears to be a significant change in pattern. In the urines
from the cases of prostatic disease there is a consistent preponderance of peak v
over peak IV. This is illustrated in Fig. 3, in which the relative amounts of the
AX __
100
,sg-
200
100
Dehydroisoandrosterone Androsterone Aetiocholanolone
FIG. 3.-Relative excretions of dehydroisoandrosterone, androsterone and aetiocholanolone in
normal males and in males with prostatic disease.
Cases 13-18, normal.
Cases 19-20, prostatic hyperplasia.
Cases 21-26, prostatic carcinoma.
Amounts of dehydroisoandrosterone and aetiocholanolone are shown relative to the same amount
(100ug.) of androsterone in all cases.
three major peaks are shown for extracts prepared from urines of six normal
males over 50 years of age (Cases 13-18), and from the urines of two subjects
with prostatic hyperplasia (Cases 19 and 20), and six patients with carcinoma of
the prostate (Cases 21-26). UTrines from the carcinoma cases were obtained
before oestrogen therapy was begun, and those from the benign hyperplasias
before operation. For convenience of comparison, the amounts of peaks In and
v are shown relative to the same amount (100lg.) of peak rv (androsterone) in
all cases. It will be seen that the most striking feature is the relative increase in
peak v in the cases suffering from prostatic disease. In the normal males over
50 years of age the amount of this peak is equal to or less than the amount of
androsterone, but in the 8 cases of prostatic disease it is present in considerable
excess.
As mentioned earlier, the preliminary experiments with known mixtures of
17-ketosteroids showed that peak v normally indicates the presence of aetio-
cholanolone, and the total amount represented by this peak is a measure of the
quantity ofthis steroid in the original mixture. It may be provisionally assumed,
therefore, that the increased size of this peak in prostatic disease indicates a
19 20 21 22 23 24 25 26
1 '1l1lA,lAl1Al
7 13 14 15 16 1-If 18
N
I. I U. t A-fl
I
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relative increase in the output of aetiocholan-3-(x)-ol-17-one, although the possi-
bility is not excluded that the incrased peak size is caused by the inclusion of
a second substance (of at present unknown nature) which is eluted with the
aetiocholanolone. A decision on this question can be made only when sufficient
of the material present in this peak has been accumulated to allow of its identi-
fication, and experiments are in progress with this object in view.
If it is assumed that aetiocholanolone is the substance that is increased in
relative amount in prostatic disease, the cause of this increase is at the moment
obscure. This ketosteroid has been recognized as a transformation product of
more than one other steroid. Callow (1939) isolated aetiocholanolone and
androsterone in approximately equ%l amounts from the urine ofnormal men, and
also much larger, but still approximately equal, amounts from the urine of a
man treated with testosterone. These two isomers appear to be end-products
of testosterone metabolism, and to be formed in about equal amounts from this
hormone. An explanation ofincreased testosterone metabolism does.not appear
to fit the present observations, however, since they show an increase in aetio-
cholanolone relative to androsterone. In this connection it may be remarked
that Callow's finding ofapproximatelyequal amounts ofthese two ketosteroids in
normal male urine was based on experiments with a pooled sample of urine,
and an examination ofTable I shows that in individual urines the ratio between
the amounts of androsterone and aetiocholanolone is not constant, although the
average values are approximately equal.
Aetiocholan-3-(c)-ol-17-one hasalso been shown to be a metabolite ofdehydro-
soandrosterone. Mason and Kepler (1945, 1947) found that administration of
dehydroandsterone acetate by intramuscular injection in oil to patients
with very low outputs of 17-ketosteroids (a man with anteriorpituitarydeficiency
and a man and a womanwith Addison'sdisease) led to greatly increasedexcretion
ofboth aetiocholanolone and androsterone. In the two male subjects the amount
of androsterone excreted exceeded that of aetiocholanolone by approximately
75 per cent, while in the female patient the aetiocholanolone was about 4-5 times
as much as the androsterone.
The observed increase in the ratio of aetiocholanolone to androsterone in the
cases ofprostaticdisease might beproduced byanincrease in the absolute amount
of aetiocholanolone, or by a decrease in the absolute amount of androsterone
excreted, or by both simultaneously. Theamounts of3-(,)-hydroxyketosteroids,
androsterone and aetiocholanolone excreted in 24-hours were calculated for the
cases illustrated in Fig. 3. The results showed that the average daily excretion
ofaetiocholanolone in the two groups of cases (normal andprostatic disease) were
approximately equal (2-0 and 1-9 mg. per day respectively), but that the andro-
sterone excretion in the normal group (2-2 mg. per day) exceeded that of the
prostatic group (1-25 mg. per day). These figures appear to support the con-
clusion that the actual difference between the two groups of subjects consists in
a diminished output of androsterone by the prostatic group. This conclusion
must, however, be regarded as provisional. Calculation of the daily excretions
corresponding to peaks m, iv and v for all the cases shown in Table I indicates
that there is a gradual decline with advancing age of each of these groups of
substances, and hence the absolute excretions shown by the prostatic group
(average age 65 years) should more properly be compared with a group ofnormal
men ofthe same average age rather than with the slightly younger group (average
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age 59 years) shown in Fig. 3. Such a comparison will be possible when further
normal males in the later decades have been examined.
In a study of z-ketosteroid excretion in patients with neoplastic disease
Dobriner, Rhoads, Lieberman, Hill and Fieser (1944) found abnormal patterns in
several cancerous conditions. In the one case of prostatic cancer reported in
their paper there was a great excess ofaetiocholanolone as compared with andro-
sterone. They found a similar relation in a case of carcinoma of the larynx and
a case of carcinoma ofthe breast. From the present results it appears, however,
that such a relation is not necessarily characteristic of neoplastic disease, since
the two cases of benign hyperplasia (Cases 19 and 20) show the same excess of
aetiocholanolone; in one of them, indeed (Case 20), aetiocholanolone is present in
greater excess than in any ofthe neoplastic cases.
Whatever the ultimate explanation may be of the relative increase of aetio-
cholanolone, it will be of great interest to investigate the effect of oestrogen
therapyontheurinary 17-ketosteroidpattern inthese casesofprostatic carcinoma.
Material has been collected for this purpose and is being examined.
S1MARY.
Methods for the cbromatographic separation and estimation of 17-ketosteroids
in urine extracts are discussed, and a standard technique which vields repro-
ducible analyses is described.
Urines from 19 normal males ranging in age from 3 to 73 years and urines
from 2 cases of benignhyperplasia of the prostate and from 6 cases of carcinoma
of this gland were examined by this method.
In normal males the amounts of androsterone and of aetiocholan-3-(x)-ol-17-
one are approximately equal, but in prostatic disease the latter substance is
present in relative excess.
The significance of this observation is discussed.
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